Experiment: 8BVZ

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.766 mM SEM1(49-67)	95% H2O/5% D2O	0 mM	3.5	1 atm	298	Bruker AVANCE III HD 700
2	2D 1H-1H TOCSY	0.766 mM SEM1(49-67)	95% H2O/5% D2O	0 mM	3.5	1 atm	298	Bruker AVANCE II 500
3	2D 1H-1H NOESY	0.766 mM SEM1(49-67)	95% H2O/5% D2O	0 mM	3.5	1 atm	298	Bruker AVANCE II 500
4	2D 1H-1H ROESY	0.766 mM SEM1(49-67)	95% H2O/5% D2O	0 mM	3.5	1 atm	298	Bruker AVANCE II 500
5	2D 1H-13C HSQC	0.766 mM SEM1(49-67)	95% H2O/5% D2O	0 mM	3.5	1 atm	298	Bruker AVANCE II 500
6	2D 1H-13C HMBC	0.766 mM SEM1(49-67)	95% H2O/5% D2O	0 mM	3.5	1 atm	298	Bruker AVANCE II 500

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE II	500
2	Bruker	AVANCE III HD	700

NMR Refinement
Method	Details	Software
molecular dynamics		X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	back calculated data agree with experimental NOESY spectrum
Conformers Calculated Total Number	100
Conformers Submitted Total Number	15
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin	3.2	Bruker Biospin
2	chemical shift assignment	CcpNmr Analysis	3.1	CCPN
3	processing	TopSpin	3.2	Bruker Biospin
4	peak picking	CcpNmr Analysis	3.1	CCPN
5	structure calculation	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.